What is BioMarin Pharmaceuticals's gross profit?

BioMarin Pharmaceuticals (BMRN) reported gross profit of $571.21M in Q1 2026.

How has BioMarin Pharmaceuticals's gross profit changed year-over-year?

BioMarin Pharmaceuticals's gross profit decreased by 3.8% year-over-year, from $593.59M to $571.21M.

What is the long-term trend for BioMarin Pharmaceuticals's gross profit?

Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's gross profit has grown at a 16.1% compound annual growth rate (CAGR), from $1.38B to $2.5B.

BioMarin Pharmaceuticals BMRN Gross Profit

Gross Profit at other companies

BiogenBIIB

$1.82B+0.8%

Vertex PharmaceuticalsVRTX

$2.59B+7.8%

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

ModernaMRNA

——

Other financials

Income statement

See full

Revenue$766.2M+2.8%

Operating income$129.6M-42.1%

Net income$105.5M-43.2%

EPS (diluted)$0.54-43.2%

Balance sheet

See full

Cash & equivalents$3.1B+193%

Total debt$1.4B+138%

Total equity$6.2B+7.2%

Total assets$8.6B+20.2%

Cash flow

See full

Operating cash flow$220.7M+26.5%

CapEx$20.9M+24.8%

Free cash flow$199.7M+26.7%

Valuation

See full

Market cap$10.57B-19.4%

Enterprise value$8.93B-29.3%

P/E21.1×-22.7×

P/S3.3×-1.2×

Profitability

See full

Gross margin76.5%-2.9pp

Operating margin19.9%+7.2pp

Net margin16.8%+5.1pp

FCF margin23.7%+2.5pp

Returns & leverage

See full

Return on equity9.1%+2.8pp

Debt / equity0.2×+0.1×

Current ratio5.8×+0.3×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

$766.2Mtotal revenue−$195.0Mtotal cost of revenue=$571.21M

The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioMarin Pharmaceuticals's gross profit?: BioMarin Pharmaceuticals (BMRN) reported gross profit of $571.21M in Q1 2026.
How has BioMarin Pharmaceuticals's gross profit changed year-over-year?: BioMarin Pharmaceuticals's gross profit decreased by 3.8% year-over-year, from $593.59M to $571.21M.
What is the long-term trend for BioMarin Pharmaceuticals's gross profit?: Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's gross profit has grown at a 16.1% compound annual growth rate (CAGR), from $1.38B to $2.5B.